1. Home
  2. GDOT vs IVA Comparison

GDOT vs IVA Comparison

Compare GDOT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDOT
  • IVA
  • Stock Information
  • Founded
  • GDOT 1999
  • IVA 2011
  • Country
  • GDOT United States
  • IVA France
  • Employees
  • GDOT N/A
  • IVA N/A
  • Industry
  • GDOT Finance: Consumer Services
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDOT Finance
  • IVA Health Care
  • Exchange
  • GDOT Nasdaq
  • IVA Nasdaq
  • Market Cap
  • GDOT 742.3M
  • IVA 769.0M
  • IPO Year
  • GDOT 2010
  • IVA 2020
  • Fundamental
  • Price
  • GDOT $12.71
  • IVA $5.28
  • Analyst Decision
  • GDOT Sell
  • IVA Strong Buy
  • Analyst Count
  • GDOT 2
  • IVA 7
  • Target Price
  • GDOT $11.00
  • IVA $16.57
  • AVG Volume (30 Days)
  • GDOT 729.0K
  • IVA 124.5K
  • Earning Date
  • GDOT 11-06-2025
  • IVA 09-29-2025
  • Dividend Yield
  • GDOT N/A
  • IVA N/A
  • EPS Growth
  • GDOT N/A
  • IVA N/A
  • EPS
  • GDOT N/A
  • IVA N/A
  • Revenue
  • GDOT $1,922,023,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • GDOT $22.03
  • IVA N/A
  • Revenue Next Year
  • GDOT $12.21
  • IVA N/A
  • P/E Ratio
  • GDOT N/A
  • IVA N/A
  • Revenue Growth
  • GDOT 22.09
  • IVA N/A
  • 52 Week Low
  • GDOT $6.13
  • IVA $2.11
  • 52 Week High
  • GDOT $15.41
  • IVA $6.55
  • Technical
  • Relative Strength Index (RSI)
  • GDOT 46.44
  • IVA 49.41
  • Support Level
  • GDOT $12.08
  • IVA $4.70
  • Resistance Level
  • GDOT $12.79
  • IVA $5.47
  • Average True Range (ATR)
  • GDOT 0.48
  • IVA 0.43
  • MACD
  • GDOT -0.09
  • IVA -0.10
  • Stochastic Oscillator
  • GDOT 44.32
  • IVA 40.43

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: